Sarepta 治療公司
MX ˙ BMV ˙ US8036071004
SecurityMX:SRPT / Sarepta Therapeutics, Inc.
InstitutionMarshall Wace, Llp
Latest Disclosed Ownership725,068 shares
Latest Disclosed Value $ 15,777,479
Marshall Wace, Llp ownership in SRPT / Sarepta Therapeutics, Inc.

On May 14, 2026 - Marshall Wace, Llp filed a 13F-HR form disclosing ownership of 725,068 shares of Sarepta Therapeutics, Inc. (MX:SRPT) valued at $15,777,479 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 13, 2026 disclosing 143,493 shares of Sarepta Therapeutics, Inc.. This represents a change in shares of 405.30% during the quarter.

Marshall Wace, Llp has a history of taking positions in derivatives of the underlying security (SRPT) in the form of stock options.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

MX:SRPT / Sarepta Therapeutics, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F SAREPTA THERAPEU COMMON STOCK 803607100 725,068 581,575 405.30 15,777 411.08 0.0074
2026-02-13 2025-12-31 13F SAREPTA THERAPEU COMMON STOCK 803607100 143,493 38,380 36.51 3,088 52.44 0.0028
2025-11-13 2025-09-30 13F SAREPTA THERAPEU COMMON STOCK 803607100 105,113 105,113 2,026 0.0021
2025-08-13 2025-06-30 13F SAREPTA THERAPEU COMMON STOCK 803607100 0 -27,197 -100.00 0 -100.00
2025-05-15 2025-03-31 13F SAREPTA THERAPEU COMMON STOCK 803607100 27,197 27,197 1,736 0.0022
2025-02-13 2024-12-31 13F SAREPTA THERAPEU COMMON STOCK 803607100 0 -42,938 -100.00 0 -100.00
2024-11-14 2024-09-30 13F SAREPTA THERAPEU COMMON STOCK 803607100 42,938 -397 -0.92 5,363 -21.68 0.0065
2024-08-14 2024-06-30 13F SAREPTA THERAPEU COMMON STOCK 803607100 43,335 39,992 1,196.29 6,847 1,484.72 0.0091
2024-05-15 2024-03-31 13F SAREPTA THERAPEU COMMON STOCK 803607100 3,343 3,343 433 0.0007
2024-02-14 2023-12-31 13F SAREPTA THERAPEU COMMON STOCK 803607100 0 -245,928 -100.00 0 -100.00
2023-11-14 2023-09-30 13F SAREPTA THERAPEU COMMON STOCK 803607100 245,928 186,886 316.53 29,811 340.93 0.0604
2023-08-14 2023-06-30 13F SAREPTA THERAPEU COMMON STOCK 803607100 59,042 -120,217 -67.06 6,761 -72.64 0.0132
2023-05-15 2023-03-31 13F SAREPTA THERAPEU COMMON STOCK 803607100 179,259 -6,746 -3.63 24,707 2.51 0.0525
2023-02-14 2022-12-31 13F SAREPTA THERAPEU COMMON STOCK 803607100 186,005 186,005 24,103 0.0542
2022-05-16 2022-03-31 13F SAREPTA THERAPEU COMMON STOCK 803607100 0 -503,638 -100.00 0 -100.00
2022-02-14 2021-12-31 13F SAREPTA THERAPEU COMMON STOCK 803607100 503,638 500,289 14,938.46 45,352 14,529.68 0.0838
2021-11-15 2021-09-30 13F SAREPTA THERAPEU COMMON STOCK 803607100 3,349 -16,170 -82.84 310 -79.56 0.0013
2021-08-13 2021-06-30 13F SAREPTA THERAPEU COMMON STOCK 803607100 19,519 -3,617 -15.63 1,517 -12.06 0.0074
2021-05-17 2021-03-31 13F SAREPTA THERAPEU COMMON STOCK 803607100 23,136 23,136 18.53 1,725 13.71 0.0079
2020-02-14 2019-12-31 13F SAREPTA THERAPEU COMMON STOCK 803607100 0 -24,153 -100.00 0 -100.00
2019-11-14 2019-09-30 13F SAREPTA THERAPEU COMMON STOCK 803607100 24,153 24,153 1,819 0.0143
2019-08-14 2019-06-30 13F SAREPTA THERAPEU COMMON STOCK 803607100 0 -5,967 -100.00 0 -100.00
2019-05-29 2019-03-31 13F/A-1 SAREPTA THERAPEU COMMON STOCK 803607100 5,967 -4,439 -42.66 711 -37.41 0.0067
2019-05-14 2019-03-31 13F SAREPTA THERAPEU COMMON STOCK 803607100 5,967 -4,439 711
2019-02-14 2018-12-31 13F SAREPTA THERAPEU COMMON STOCK 803607100 10,406 10,406 74.39 1,136 59.77 0.0116
2018-11-14 2018-09-30 13F SAREPTA THERAPEU COMMON STOCK 803607100 0 -3,667 -100.00 0 -100.00
2018-08-14 2018-06-30 13F SAREPTA THERAPEU COMMON STOCK 803607100 3,667 -4,321 -54.09 485 -18.07 0.0073
2018-05-15 2018-03-31 13F SAREPTA THERAPEU COMMON STOCK 803607100 7,988 1,845 30.03 592 73.10 0.0245
2018-03-29 2017-12-31 13F/A-1 SAREPTA THERAPEU COMMON STOCK 803607100 6,143 -21,670 -77.91 342 -72.68 0.0144
2018-02-14 2017-12-31 13F SAREPTA THERAPEU COMMON STOCK 803607100 6,143 -21,670 342
2017-11-13 2017-09-30 13F SAREPTA THERAPEU COMMON STOCK 803607100 27,813 27,813 352.76 1,252 266.08 0.0582
2015-08-14 2015-06-30 13F SAREPTA THERAPEU COMMON STOCK 803607100 0 -11,296 -100.00 0 -100.00
2015-05-11 2015-03-31 13F SAREPTA THERAPEU COMMON STOCK 803607100 11,296 11,296 150 0.0020
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2017-02-10 2016-12-31 13F SRPT US 11 EQUITY OPTION Put 0 -100.00 0 -100.00 n/a n/a n/a
2016-11-10 2016-09-30 13F SRPT US 11 EQUITY OPTION Put 210,000 8,961 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.